Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release - Orchid Pharma''s ''Exblifeb'' granted European Medicines agency approval - A landmark achievement for India''s Pharmaceutical Industry Orchid Pharma Ltd - 524372 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance certificate under regulation 74(5) of SEBI (DP) Regulation, 2018
Orchid Pharma - A Preferred Play On Import Substitution Opportunity: Systematix Initiates Coverage With A Buy
Initiate coverage on Orchid Pharma with a 'Buy' rating and a target price of Rs 884, based on 30 times FY26E earnings per share. Orchid Pharma Ltd - 524372 - Closure of Trading Window
Trading Window for dealing/trading in securities of the Company shall remain closed from January 01, 2024 till 48 hours after declaration of the financial results of the quarter ending on December 31, 2023. Orchid Pharma Ltd - 524372 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBICAP Trustee Company Ltd Orchid Pharma Ltd - 524372 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBICAP Trustee Company Ltd Orchid Pharma Ltd - 524372 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBICAP Trustee Company Ltd Orchid Pharma Ltd - 524372 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Massachusetts Institute of Technology & PACs Orchid Pharma Ltd - 524372 - Appointment of Company Secretary and Compliance Officer
The Board of Directors of the Company on the recommendation of the Nomination & Remuneration Committee appointed Company Secretary and Compliance officer of the Company. Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Credit Rating
In terms of the SEBI Listing Regulations, this is to inform that CARE Ratings Limited has revised the status of the ratings assigned to the Company.